98 related articles for article (PubMed ID: 9295186)
1. The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication).
Martin P; Waters N; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 1997; 104(4-5):561-4. PubMed ID: 9295186
[TBL] [Abstract][Full Text] [Related]
2. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
[TBL] [Abstract][Full Text] [Related]
3. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
Varty GB; Bakshi VP; Geyer MA
Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
[TBL] [Abstract][Full Text] [Related]
4. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
Carlsson ML; Martin P; Nilsson M; Sorensen SM; Carlsson A; Waters S; Waters N
J Neural Transm (Vienna); 1999; 106(2):123-9. PubMed ID: 10226932
[TBL] [Abstract][Full Text] [Related]
5. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
Martin P; Waters N; Waters S; Carlsson A; Carlsson ML
Eur J Pharmacol; 1997 Sep; 335(2-3):107-16. PubMed ID: 9369362
[TBL] [Abstract][Full Text] [Related]
6. A behavioural pattern analysis of hypoglutamatergic mice--effects of four different antipsychotic agents.
Nilsson M; Waters S; Waters N; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 2001; 108(10):1181-96. PubMed ID: 11725821
[TBL] [Abstract][Full Text] [Related]
7. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors.
Su YA; Si TM; Zhou DF; Guo CM; Wang XD; Yang Y; Shu L; Liang JH
Eur J Pharmacol; 2007 Jun; 564(1-3):123-30. PubMed ID: 17395179
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB.
O'Neill MF; Heron-Maxwell CL; Shaw G
Pharmacol Biochem Behav; 1999 Jun; 63(2):237-43. PubMed ID: 10371652
[TBL] [Abstract][Full Text] [Related]
9. Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.
Kehne JH; Baron BM; Carr AA; Chaney SF; Elands J; Feldman DJ; Frank RA; van Giersbergen PL; McCloskey TC; Johnson MP; McCarty DR; Poirot M; Senyah Y; Siegel BW; Widmaier C
J Pharmacol Exp Ther; 1996 May; 277(2):968-81. PubMed ID: 8627580
[TBL] [Abstract][Full Text] [Related]
10. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
Arvanov VL; Wang RY
Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117
[TBL] [Abstract][Full Text] [Related]
11. High 5HT2A receptor occupancy in M100907-treated schizophrenic patients.
Talvik-Lotfi M; Nyberg S; Nordström AL; Ito H; Halldin C; Brunner F; Farde L
Psychopharmacology (Berl); 2000 Mar; 148(4):400-3. PubMed ID: 10928313
[TBL] [Abstract][Full Text] [Related]
12. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.
O'Neill MF; Hicks CA; Shaw G; Parameswaran T; Cardwell GP; O'Neill MJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):839-46. PubMed ID: 9864262
[TBL] [Abstract][Full Text] [Related]
13. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.
Wang RY; Liang X
Neuropsychopharmacology; 1998 Jul; 19(1):74-85. PubMed ID: 9608579
[TBL] [Abstract][Full Text] [Related]
14. 5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.
Ferguson MC; Nayyar T; Deutch AY; Ansah TA
Neuropharmacology; 2010; 59(1-2):31-6. PubMed ID: 20361986
[TBL] [Abstract][Full Text] [Related]
15. The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis.
Carlsson ML
J Neural Transm Gen Sect; 1995; 100(3):225-37. PubMed ID: 8748668
[TBL] [Abstract][Full Text] [Related]
16. 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion.
Ninan I; Kulkarni SK
Eur J Pharmacol; 1998 Oct; 358(2):111-6. PubMed ID: 9808259
[TBL] [Abstract][Full Text] [Related]
17. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
Kehne JH; Ketteler HJ; McCloskey TC; Sullivan CK; Dudley MW; Schmidt CJ
Neuropsychopharmacology; 1996 Aug; 15(2):116-24. PubMed ID: 8840347
[TBL] [Abstract][Full Text] [Related]
18. Risperidone and ritanserin but not haloperidol block effect of dizocilpine on the active allothetic place avoidance task.
Bubenikova-Valesova V; Stuchlik A; Svoboda J; Bures J; Vales K
Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1061-6. PubMed ID: 18195350
[TBL] [Abstract][Full Text] [Related]
19. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
[TBL] [Abstract][Full Text] [Related]
20. Clozapine Improves Behavioral and Biochemical Outcomes in a MK-801-Induced Mouse Model of Schizophrenia.
Andrabi SS; Vishnoi S; Madan R; Bhardwaj N; Tabassum H; Akram M; Parvez S
J Environ Pathol Toxicol Oncol; 2020; 39(1):1-12. PubMed ID: 32479008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
